Logo image of LIN.DE

LINDE PLC (LIN.DE) Stock Fundamental Analysis

FRA:LIN - Deutsche Boerse Ag - IE000S9YS762 - Common Stock - Currency: EUR

430.4  -3.4 (-0.78%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to LIN. LIN was compared to 61 industry peers in the Chemicals industry. While LIN has a great profitability rating, there are some minor concerns on its financial health. While showing a medium growth rate, LIN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

LIN had positive earnings in the past year.
In the past year LIN had a positive cash flow from operations.
In the past 5 years LIN has always been profitable.
LIN had a positive operating cash flow in each of the past 5 years.
LIN.DE Yearly Net Income VS EBIT VS OCF VS FCFLIN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

1.2 Ratios

LIN has a Return On Assets of 8.19%. This is amongst the best in the industry. LIN outperforms 88.89% of its industry peers.
The Return On Equity of LIN (17.23%) is better than 93.65% of its industry peers.
With an excellent Return On Invested Capital value of 9.68%, LIN belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for LIN is in line with the industry average of 6.72%.
The 3 year average ROIC (8.66%) for LIN is below the current ROIC(9.68%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.19%
ROE 17.23%
ROIC 9.68%
ROA(3y)7.02%
ROA(5y)5.72%
ROE(3y)14.4%
ROE(5y)11.44%
ROIC(3y)8.66%
ROIC(5y)7.15%
LIN.DE Yearly ROA, ROE, ROICLIN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

LIN has a Profit Margin of 19.89%. This is amongst the best in the industry. LIN outperforms 93.65% of its industry peers.
In the last couple of years the Profit Margin of LIN has grown nicely.
LIN has a Operating Margin of 26.60%. This is amongst the best in the industry. LIN outperforms 98.41% of its industry peers.
In the last couple of years the Operating Margin of LIN has grown nicely.
LIN's Gross Margin of 48.06% is fine compared to the rest of the industry. LIN outperforms 74.60% of its industry peers.
LIN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 26.6%
PM (TTM) 19.89%
GM 48.06%
OM growth 3Y15.55%
OM growth 5Y18.08%
PM growth 3Y16.98%
PM growth 5Y19.7%
GM growth 3Y3.75%
GM growth 5Y3.21%
LIN.DE Yearly Profit, Operating, Gross MarginsLIN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), LIN is creating some value.
The number of shares outstanding for LIN has been reduced compared to 1 year ago.
The number of shares outstanding for LIN has been reduced compared to 5 years ago.
The debt/assets ratio for LIN is higher compared to a year ago.
LIN.DE Yearly Shares OutstandingLIN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
LIN.DE Yearly Total Debt VS Total AssetsLIN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

An Altman-Z score of 4.12 indicates that LIN is not in any danger for bankruptcy at the moment.
LIN has a better Altman-Z score (4.12) than 88.89% of its industry peers.
The Debt to FCF ratio of LIN is 4.39, which is a neutral value as it means it would take LIN, 4.39 years of fcf income to pay off all of its debts.
LIN has a better Debt to FCF ratio (4.39) than 79.37% of its industry peers.
A Debt/Equity ratio of 0.51 indicates that LIN is somewhat dependend on debt financing.
LIN has a Debt to Equity ratio of 0.51. This is comparable to the rest of the industry: LIN outperforms 52.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF 4.39
Altman-Z 4.12
ROIC/WACC1.09
WACC8.84%
LIN.DE Yearly LT Debt VS Equity VS FCFLIN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.3 Liquidity

LIN has a Current Ratio of 0.89. This is a bad value and indicates that LIN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of LIN (0.89) is worse than 80.95% of its industry peers.
A Quick Ratio of 0.76 indicates that LIN may have some problems paying its short term obligations.
LIN has a Quick ratio of 0.76. This is in the lower half of the industry: LIN underperforms 79.37% of its industry peers.
Industry RankSector Rank
Current Ratio 0.89
Quick Ratio 0.76
LIN.DE Yearly Current Assets VS Current LiabilitesLIN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

LIN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.15%, which is quite good.
Measured over the past years, LIN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.11% on average per year.
LIN shows a small growth in Revenue. In the last year, the Revenue has grown by 0.46%.
Measured over the past years, LIN shows a small growth in Revenue. The Revenue has been growing by 3.18% on average per year.
EPS 1Y (TTM)9.15%
EPS 3Y13.21%
EPS 5Y16.11%
EPS Q2Q%10.58%
Revenue 1Y (TTM)0.46%
Revenue growth 3Y2.34%
Revenue growth 5Y3.18%
Sales Q2Q%-0.24%

3.2 Future

LIN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.98% yearly.
The Revenue is expected to grow by 5.11% on average over the next years.
EPS Next Y7.39%
EPS Next 2Y8.65%
EPS Next 3Y9.89%
EPS Next 5Y7.98%
Revenue Next Year1.76%
Revenue Next 2Y3.68%
Revenue Next 3Y4.12%
Revenue Next 5Y5.11%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LIN.DE Yearly Revenue VS EstimatesLIN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B 40B
LIN.DE Yearly EPS VS EstimatesLIN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15 20

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 30.12, LIN can be considered very expensive at the moment.
LIN's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 29.35. LIN is around the same levels.
With a Price/Forward Earnings ratio of 28.06, LIN can be considered very expensive at the moment.
LIN's Price/Forward Earnings is on the same level as the industry average.
LIN's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 22.10.
Industry RankSector Rank
PE 30.12
Fwd PE 28.06
LIN.DE Price Earnings VS Forward Price EarningsLIN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as LIN.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of LIN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 44.86
EV/EBITDA 18.59
LIN.DE Per share dataLIN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of LIN may justify a higher PE ratio.
PEG (NY)4.08
PEG (5Y)1.87
EPS Next 2Y8.65%
EPS Next 3Y9.89%

3

5. Dividend

5.1 Amount

LIN has a Yearly Dividend Yield of 1.29%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.89, LIN is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.33, LIN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.29%

5.2 History

On average, the dividend of LIN grows each year by 9.64%, which is quite nice.
Dividend Growth(5Y)9.64%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

40.44% of the earnings are spent on dividend by LIN. This is a bit on the high side, but may be sustainable.
LIN's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP40.44%
EPS Next 2Y8.65%
EPS Next 3Y9.89%
LIN.DE Yearly Income VS Free CF VS DividendLIN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B
LIN.DE Dividend Payout.LIN.DE Dividend Payout, showing the Payout Ratio.LIN.DE Dividend Payout.PayoutRetained Earnings

LINDE PLC

FRA:LIN (3/7/2025, 7:00:00 PM)

430.4

-3.4 (-0.78%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-06 2025-02-06/bmo
Earnings (Next)04-30 2025-04-30/bmo
Inst Owners86.92%
Inst Owner ChangeN/A
Ins Owners0.18%
Ins Owner ChangeN/A
Market Cap203.54B
Analysts76.97
Price Target486.02 (12.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.29%
Yearly Dividend5.1
Dividend Growth(5Y)9.64%
DP40.44%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.17%
Min EPS beat(2)0.12%
Max EPS beat(2)0.22%
EPS beat(4)4
Avg EPS beat(4)0.52%
Min EPS beat(4)0.12%
Max EPS beat(4)1.02%
EPS beat(8)8
Avg EPS beat(8)1.8%
EPS beat(12)12
Avg EPS beat(12)2.88%
EPS beat(16)16
Avg EPS beat(16)3.35%
Revenue beat(2)0
Avg Revenue beat(2)-1.62%
Min Revenue beat(2)-2.37%
Max Revenue beat(2)-0.88%
Revenue beat(4)0
Avg Revenue beat(4)-2.25%
Min Revenue beat(4)-4.18%
Max Revenue beat(4)-0.88%
Revenue beat(8)1
Avg Revenue beat(8)-2.63%
Revenue beat(12)4
Avg Revenue beat(12)-1.87%
Revenue beat(16)8
Avg Revenue beat(16)-0.78%
PT rev (1m)0.42%
PT rev (3m)0.39%
EPS NQ rev (1m)-1.83%
EPS NQ rev (3m)-3.19%
EPS NY rev (1m)-2.24%
EPS NY rev (3m)-2.76%
Revenue NQ rev (1m)-2.05%
Revenue NQ rev (3m)-2.81%
Revenue NY rev (1m)-2.89%
Revenue NY rev (3m)-3.42%
Valuation
Industry RankSector Rank
PE 30.12
Fwd PE 28.06
P/S 6.7
P/FCF 44.86
P/OCF 23.45
P/B 5.8
P/tB 267.86
EV/EBITDA 18.59
EPS(TTM)14.29
EY3.32%
EPS(NY)15.34
Fwd EY3.56%
FCF(TTM)9.59
FCFY2.23%
OCF(TTM)18.35
OCFY4.26%
SpS64.28
BVpS74.19
TBVpS1.61
PEG (NY)4.08
PEG (5Y)1.87
Profitability
Industry RankSector Rank
ROA 8.19%
ROE 17.23%
ROCE 13.38%
ROIC 9.68%
ROICexc 10.4%
ROICexgc 24.39%
OM 26.6%
PM (TTM) 19.89%
GM 48.06%
FCFM 14.93%
ROA(3y)7.02%
ROA(5y)5.72%
ROE(3y)14.4%
ROE(5y)11.44%
ROIC(3y)8.66%
ROIC(5y)7.15%
ROICexc(3y)9.32%
ROICexc(5y)7.64%
ROICexgc(3y)23.11%
ROICexgc(5y)19.12%
ROCE(3y)12%
ROCE(5y)9.82%
ROICexcg growth 3Y14.97%
ROICexcg growth 5Y24.05%
ROICexc growth 3Y19.06%
ROICexc growth 5Y24.87%
OM growth 3Y15.55%
OM growth 5Y18.08%
PM growth 3Y16.98%
PM growth 5Y19.7%
GM growth 3Y3.75%
GM growth 5Y3.21%
F-Score8
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF 4.39
Debt/EBITDA 1.56
Cap/Depr 118.97%
Cap/Sales 13.63%
Interest Coverage 250
Cash Conversion 75.02%
Profit Quality 75.03%
Current Ratio 0.89
Quick Ratio 0.76
Altman-Z 4.12
F-Score8
WACC8.84%
ROIC/WACC1.09
Cap/Depr(3y)97.89%
Cap/Depr(5y)86.75%
Cap/Sales(3y)11.55%
Cap/Sales(5y)11.43%
Profit Quality(3y)100.43%
Profit Quality(5y)127.18%
High Growth Momentum
Growth
EPS 1Y (TTM)9.15%
EPS 3Y13.21%
EPS 5Y16.11%
EPS Q2Q%10.58%
EPS Next Y7.39%
EPS Next 2Y8.65%
EPS Next 3Y9.89%
EPS Next 5Y7.98%
Revenue 1Y (TTM)0.46%
Revenue growth 3Y2.34%
Revenue growth 5Y3.18%
Sales Q2Q%-0.24%
Revenue Next Year1.76%
Revenue Next 2Y3.68%
Revenue Next 3Y4.12%
Revenue Next 5Y5.11%
EBIT growth 1Y8.88%
EBIT growth 3Y18.26%
EBIT growth 5Y21.83%
EBIT Next Year43.02%
EBIT Next 3Y18.28%
EBIT Next 5Y11.51%
FCF growth 1Y-10.73%
FCF growth 3Y-9.47%
FCF growth 5Y14.47%
OCF growth 1Y1.27%
OCF growth 3Y-1.05%
OCF growth 5Y8.77%